Abstract

The identification of genes essential for bacterial growth and survival represents a promising strategy for the discovery of antimicrobial targets. Essential genes can be identified on a genome-scale using transposon mutagenesis approaches; however, variability between screens and challenges with interpretation of essentiality data hinder the identification of both condition-independent and condition-dependent essential genes. To illustrate the scope of these challenges, we perform a large-scale comparison of multiple published Pseudomonas aeruginosa gene essentiality datasets, revealing substantial differences between the screens. We then contextualize essentiality using genome-scale metabolic network reconstructions and demonstrate the utility of this approach in providing functional explanations for essentiality and reconciling differences between screens. Genome-scale metabolic network reconstructions also enable a high-throughput, quantitative analysis to assess the impact of media conditions on the identification of condition-independent essential genes. Our computational model-driven analysis provides mechanistic insight into essentiality and contributes novel insights for design of future gene essentiality screens and the identification of core metabolic processes.

Highlights

  • With the rise of antibiotic resistance, there is a growing need to discover new therapeutic targets to treat bacterial infections

  • Essential genes can be identified with transposon mutagenesis approaches; variability between screens and challenges with interpretation of essentiality data hinder the identification and analysis of essential genes

  • The integration of computational modeling with high-throughput experimental screens may enable the identification of drug targets with high-confidence and provide greater understanding for the development of novel therapeutic strategies

Read more

Summary

Introduction

With the rise of antibiotic resistance, there is a growing need to discover new therapeutic targets to treat bacterial infections. One attractive strategy is to target genes that are essential for growth and survival [1,2,3,4]. Discovery of such genes has been a long-standing interest, and advances in transposon mutagenesis combined with high-throughput sequencing have enabled their identification on a genome-scale. Transposon mutagenesis screens have been used to discriminate between in vivo and in vitro essential genes [1,5], discover genes uniquely required at different infection sites [6], and assess the impact of co-infection on gene essentiality status [7]. A central challenge of these screens is in interpreting why a gene is or is not essential in a given condition, hindering the identification of promising drug targets

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call